479 related articles for article (PubMed ID: 31033798)
41. Perinodular hydropic degeneration of a uterine leiomyoma: a diagnostic challenge.
Coad JE; Sulaiman RA; Das K; Staley N
Hum Pathol; 1997 Feb; 28(2):249-51. PubMed ID: 9023411
[TBL] [Abstract][Full Text] [Related]
42. POTENTIAL LIFE PROGNOSTIC MARKER FOR MESENCHYMAL TUMOR RESEMBLING UTERINE LEIOMYOSARCOMA.
Nishikawa S; Hayashi T; Uzaki T; Yaegashi N; Abiko K; Konishi I
Georgian Med News; 2023 Oct; (343):119-126. PubMed ID: 38096528
[TBL] [Abstract][Full Text] [Related]
43. Differential diagnosis between uterine sarcoma and leiomyoma using preoperative clinical characteristics.
Cho HY; Kim K; Kim YB; No JH
J Obstet Gynaecol Res; 2016 Mar; 42(3):313-8. PubMed ID: 26695124
[TBL] [Abstract][Full Text] [Related]
44. Diffuse leiomyomatosis of the uterus: a report of four cases.
Clement PB; Young RH
Int J Gynecol Pathol; 1987; 6(4):322-30. PubMed ID: 3692674
[TBL] [Abstract][Full Text] [Related]
45. MR imaging findings of unusual leiomyoma and malignant uterine myometrial tumors: what the radiologist should know.
Fujii S; Mukuda N; Ochiai R; Yunaga H; Murakami A; Gonda T; Kishimoto M; Yamaji D; Ishibashi M
Jpn J Radiol; 2021 Jun; 39(6):527-539. PubMed ID: 33517507
[TBL] [Abstract][Full Text] [Related]
46. The Clinicopathological Study of 21 Cases With Uterine Smooth Muscle Tumors of Uncertain Malignant Potential: Centralized Review Can Purify the Diagnosis.
Basaran D; Usubutun A; Salman MC; Narin MA; Boyraz G; Turkmen O; Comert Kimyon G; Karalok A; Bulbul D; Turan T; Ozgul N; Yuce K
Int J Gynecol Cancer; 2018 Feb; 28(2):233-240. PubMed ID: 29303932
[TBL] [Abstract][Full Text] [Related]
47. Atypical uterine leiomyoma: a case report and review of the literature.
Manxhuka-Kerliu S; Kerliu-Saliu I; Sahatciu-Meka V; Kerliu L; Shahini L
J Med Case Rep; 2016 Jan; 10():22. PubMed ID: 26801982
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.
Giuntoli RL; Gostout BS; DiMarco CS; Metzinger DS; Keeney GL
J Reprod Med; 2007 Nov; 52(11):1001-10. PubMed ID: 18161397
[TBL] [Abstract][Full Text] [Related]
49. Characteristic of Uterine Rhabdomyosarcoma by Algorithm of Potential Biomarkers for Uterine Mesenchymal Tumor.
Tamura S; Hayashi T; Ichimura T; Yaegashi N; Abiko K; Konishi I
Curr Oncol; 2022 Mar; 29(4):2350-2363. PubMed ID: 35448164
[TBL] [Abstract][Full Text] [Related]
50. A uterine leiomyoma in which a leiomyosarcoma with osteoclast-like giant cells and a metastasis of a ductal breast carcinoma are present.
van Meurs HS; Dieles JJ; Stel HV
Ann Diagn Pathol; 2012 Jan; 16(1):67-70. PubMed ID: 21216642
[TBL] [Abstract][Full Text] [Related]
51. A high-grade uterine leiomyosarcoma with human chorionic gonadotropin production.
Liang S; Stone G; Chalas E; Pearl M; Callan F; Zheng W
Int J Gynecol Pathol; 2006 Jul; 25(3):257-61. PubMed ID: 16810064
[TBL] [Abstract][Full Text] [Related]
52. Potential Markers to Differentiate Uterine Leiomyosarcomas from Leiomyomas.
Guo J; Zheng J; Tong J
Int J Med Sci; 2024; 21(7):1227-1240. PubMed ID: 38818470
[TBL] [Abstract][Full Text] [Related]
53. Cotyledonoid dissecting leiomyoma of the uterus: a case report and review of the literature.
Kim MJ; Park YK; Cho JH
J Korean Med Sci; 2002 Dec; 17(6):840-4. PubMed ID: 12483013
[TBL] [Abstract][Full Text] [Related]
54. High grade sarcoma with chondrosarcomatous differentiation in primary uterine leiomyosarcoma; A rare case and review of literature.
Sadiq Q; Khan F
Gynecol Oncol Rep; 2022 Feb; 39():100905. PubMed ID: 35531362
[TBL] [Abstract][Full Text] [Related]
55. Identification of uterine leiomyoma-specific marker genes based on DNA methylation and their clinical application.
Sato S; Maekawa R; Yamagata Y; Tamura I; Lee L; Okada M; Jozaki K; Asada H; Tamura H; Sugino N
Sci Rep; 2016 Aug; 6():30652. PubMed ID: 27498619
[TBL] [Abstract][Full Text] [Related]
56. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study.
Raspagliesi F; Maltese G; Bogani G; Fucà G; Lepori S; De Iaco P; Perrone M; Scambia G; Cormio G; Bogliolo S; Bergamini A; Bifulco G; Casali PG; Lorusso D
Gynecol Oncol; 2017 Jan; 144(1):90-95. PubMed ID: 27817933
[TBL] [Abstract][Full Text] [Related]
57. Raf kinase inhibitor protein expression in smooth muscle tumours of the uterus: a diagnostic marker for leiomyosarcoma?
Greco S; Pinheiro J; Cardoso-Carneiro D; Giantomassi F; Pellegrino P; Scaglione G; Delli Carpini G; Ciavattini A; Zannoni GF; Goteri G; Martinho O; Ciarmela P
Reprod Biomed Online; 2024 Jun; 48(6):103816. PubMed ID: 38608337
[TBL] [Abstract][Full Text] [Related]
58. The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors.
Atkins KA; Arronte N; Darus CJ; Rice LW
Am J Surg Pathol; 2008 Jan; 32(1):98-102. PubMed ID: 18162776
[TBL] [Abstract][Full Text] [Related]
59. Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis.
Momeni-Boroujeni A; Yousefi E; Balakrishnan R; Riviere S; Kertowidjojo E; Hensley ML; Ladanyi M; Ellenson LH; Chiang S
Mod Pathol; 2023 Apr; 36(4):100084. PubMed ID: 36788080
[TBL] [Abstract][Full Text] [Related]
60. [The differential diagnosis between uterine leiomyosarcoma and the special subtypes of leiomyoma].
Zhu XQ; Shi YF; Cheng XD; Wu YZ
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1419-21. PubMed ID: 14521746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
